News - gemcitabine Hcl

Filter

Current filters:

gemcitabine Hcl

Popular Filters

US FDA backs Abraxane for metastatic pancreatic cancer

09-09-2013

US biotech firm Celgene (Nasdaq: CELG) said on Friday (September 6) that the US Food and Drug Administration…

AbraxaneBiotechnologyCelgenegemcitabine HclNorth AmericaOncologyRegulation

Celgene's Abraxane plus gemcitabine extends survival in pancreatic cancer patients

23-01-2013

US biotech firm Celgene Corp (Nasdaq: CELG) says that its Phase III clinical trial of Abraxane (nab-paclitaxel)…

AbraxaneBiotechnologyCelgenegemcitabine HclOncologyResearch

Amgen halts ganitumab study on little hope of success

09-08-2012

USA-based Amgen (Nasdaq: AMGN), the world's largest independent biotech firm, late yesterday revealed…

AmgenBiotechnologyganitumabgemcitabine HclOncologyResearch

Hospira gains US approval of solution version of gemcitabine injection

07-08-2011

US generic injectable drug leader Hospira (NYSE: HSP) says the US Food and Drug Administration has approved…

Eli Lillygemcitabine HclGemzarGenericsHospiraNorth AmericaOncologyRegulation

Back to top